Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.721 EUR
46.02 M EUR
314.64 M EUR
47.41 M
About JAPAN LIFELINE CO
Sector
Industry
Headquarters
Tokyo
Website
Founded
1981
ISIN
JP3754500001
FIGI
BBG01S7TKNH5
Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. It operates through the following divisions: Cardiac Rhythm Management, Electrophysiology and Ablation, Cadiovascular and Vascular Surgery, and Transvascular Intervention. The Cardiac Rhythm Management division provides implantable devices to treat arrhythmias. The Electrophysiology and Ablation division offers disposable catheter devices with electrodes for the diagnosis and treatment of arrhythmias. The Cadiovascular and Vascular Surgery division handles vascular grafts to treat blood vessels. The Transvascular Intervention division deals with devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities, and congenital cardiac diseases. The company was founded by Keisuke Suzuki and Takeshi Masumoto on February 6, 1981 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange JAPAN LIFELINE CO. stocks are traded under the ticker L8B.
We've gathered analysts' opinions on JAPAN LIFELINE CO. future price: according to them, L8B price has a max estimate of 11.10 EUR and a min estimate of 10.17 EUR. Watch L8B chart and read a more detailed JAPAN LIFELINE CO. stock forecast: see what analysts think of JAPAN LIFELINE CO. and suggest that you do with its stocks.
Yes, you can track JAPAN LIFELINE CO. financials in yearly and quarterly reports right on TradingView.
JAPAN LIFELINE CO. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
JAPAN LIFELINE CO. revenue for the last quarter amounts to 91.09 M EUR, despite the estimated figure of 90.08 M EUR. In the next quarter, revenue is expected to reach 88.24 M EUR.
L8B net income for the last quarter is 16.19 M EUR, while the quarter before that showed 13.09 M EUR of net income which accounts for 23.71% change. Track more JAPAN LIFELINE CO. financial stats to get the full picture.
JAPAN LIFELINE CO. dividend yield was 3.45% in 2023, and payout ratio reached 42.54%. The year before the numbers were 4.15% and 43.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 21, 2025, the company has 1.22 K employees. See our rating of the largest employees — is JAPAN LIFELINE CO. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAPAN LIFELINE CO. EBITDA is 85.47 M EUR, and current EBITDA margin is 24.96%. See more stats in JAPAN LIFELINE CO. financial statements.
Like other stocks, L8B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAPAN LIFELINE CO. stock right from TradingView charts — choose your broker and connect to your account.